Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase and activation of its signal pathway plays an important role in regulating protein growth and synthesis as well as cell proliferation and survival. In the present study, we examined the contribution of mTOR and its downstream products to brain injuries and neurological deficiencies after cardiac arrest (CA) induced-transient global ischemia. CA was induced by asphyxia followed by cardiopulmonary resuscitation (CPR) in rats. Our results showed that expression of p-mTOR, mTORmediated phosphorylation of 4E-binding protein 4 (4E-BP1) and p70 ribosomal S6 protein kinase 1 (S6K1) pathways were amplified in CA rats compared to their controls. Blocking mTOR using rapamycin attenuated upregulation of pro-inflammatory cytokines (namely IL-1β, IL-6 and TNF-α), and Caspase-3, indicating cell apoptosis and also promoting the levels of vascular endothelial growth factor (VEGF) and its subtype receptor VEGFR-2 in the hippocampus. Moreover, the effects of rapamycin were linked to improvement of neurological deficits and increased brain water content observed in CA rats. In conclusion, activation of mTOR signal is engaged in pathophysiological process during CA-induced transient global ischemia and blocking mTOR pathway plays a beneficial role in regulating injured neuronal tissues and neurological deficits via PIC, apoptotic Caspase-3 and VEGF mechanisms. Targeting one or more of these specific mTOR pathways and its downstream signaling molecules may present new opportunities for neural dysfunction and vulnerability related to transient global ischemia.
Introduction
Previous studies have demonstrated that hypoxia inducible factor-1 (HIF-1) subtype HIF-1α is expressed in brain tissues, including cerebral cortex and hippocampus, and engages in neuronal apoptosis after induction of global ischemia [3] [4] [5] [6] . In particular, our recent study using this model has further demonstrated that CA increases IL-1β, IL-6 and TNF-α and upregulates their receptors IL-1R, IL-6R and TNFR1 in the hippocampus [7] . Systemic administration of ML228, an activator of HIF-1α [8] , attenuates these exaggerated proinflammatory cytokines (PIC) signal pathways [7] , and as a result HIF-1α activation and/or stabilization, improves neuronal apoptosis and neurological deficits induced by CA [9] .
Vascular endothelial growth factor (VEGF)
is an important signalling protein, engaged in both vasculogenesis and angiogenesis, which leads to restoring the blood supply to tissues [10] . It has been shown that VEGF stimulates endothelial cell mitogenesis and cell migration, but also enhances microvascular permeability [10] . Moreover, it has been reported that VEGF is up-regulated after CA-evoked cerebral ischemia and this likely improves the permeability of blood-brain barrier, reduces brain edema formation and promotes the recovery of brain injuries [2, 11] .
Mammalian target of rapamycin (mTOR), including complex 1 (mTORC1) and complex 2 (mTORC2), is a serine threonine protein kinase. Specifically, mTORC1 is more sensitive to rapamycin and its activation promotes the phosphorylation of downstream effectors, such as p70 ribosomal S6 protein kinase (p70S6K) which further governs mRNA translation [12] . The mTORC1 is well known for its critical roles in the regulation of protein synthesis and growth, and it has been reported to be involved in ischemic injuries after intracerebral hemorrhage. Nonetheless, the precise signal
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Materials and methods

Experimental Animals
All the animal procedures were approved by the 
Study interventions and animal groups
The rats were divided randomly. Group 1: the rats received the same surgical procedures and endotracheal intubation was performed with no asphyxia and CPR. Group 2: CA and CPR were performed and 0.5 ml of saline (i.p., every 12 hours for 3 days) was given after CA. Group 3: CA and CPR were carried out and 500 μg/kg body weight of rapamycin (i.p., every 12 hours for 3 days) was injected after CA. At the end of each experiment, the rats were sacrificed and then the brains were taken out for biochemical measurements. Note that the hippocampus CA1 region was used in this study.
Neurological examination
The modified method of Neurological Severity Score (mNSS) was used to examine neurological functions in this study [13] . Note that mNSS was generally used to assess a combination of motor, sensory, and balance functions.
Neurological function was graded on a scale of 0-18 (normal score, 0; maximal deficit score, 18). In case of mNSS score of rats > 0 before CA, they were considered abnormal and thus were excluded from the experiment. Experiments were performed in a blind manner.
Brain edema (brain water content) was determined 72 hours after CA. The brain slices (2 mm thick) of the hemispheres and cerebellum were cut. The whole brain water content was calculated from all slices [14, 15] .
The brain slices were weighed to obtain the wet weight immediately and dried in an oven at 100ºC for 24 hours to obtain the dry weight.
The cerebellum was used as the internal control. The water content was expressed as the following formula:
[(wet weight) − (dry weight)]/(wet weight) × 100%.
ELISA measurements
All the tissues from individual rats were sampled for the analysis. In brief, the hippocampus then normalised to a control sample [7, 9] .
Statistical Analysis
A two-way repeated-measure analysis of variance was used to analyse all the data in this report as a multiple set of data were compared between two groups or among three groups.
Values were presented as means ± standard deviation. Differences were considered significant at P < 0.05. All statistical analyses were performed using SPSS for Windows version 15.0 (SPSS, USA).
Results
Expression of mTOR signal pathway Effects of blocking mTOR on PICs, VEGF and VEGFR-2, and Caspase-3 Figure 2A shows that IL-1β, IL-6 and TNF-α were significantly elevated in the CA1 subfield of the hippocampus after induction of CA (P < 0.05 vs.
control rats; control rats =10 and CA rats =12) compared to control rats. Inhibition of mTOR, by administration of rapamycin, significantly decreased the amplification of IL-1β, IL-6 and TNF-α in CA rats (P < 0.05 vs. CA rats; n=15 in CA rats with rapamycin). Figure 2B illustrates that induction of CA significantly increased the levels of VEGF in the CA1 region compared to control rats (P < 0.05 vs.
control rats; control rats =10 and CA rats =12). Prior studies have demonstrated that HIF-1α is expressed in the brain tissues including the cerebral cortex and hippocampus and engaged in neuronal apoptosis after induction of global ischemia [3] [4] [5] [6] . In particular, a recent study using this model has further demonstrated that CA increases IL-1β, IL-6
and TNF-α and upregulates their receptors IL-1R, IL-6R and TNFR1 in the hippocampus [7] . Systemic activation of HIF-1α attenuates these exaggerated PIC signal pathways [7] , and as a result neuronal apoptosis and neurological deficits induced by CA are attenuated [9] .
In the present study, we administered the mTOR inhibitor rapamycin and examined in the hippocampus CA1 region. Cerebral ischemia evoked by CA amplified the levels of these PICs. Inhibition of mTOR signal, using rapamycin, decreased the augmented IL-1β, IL-6 and TNF-α in the CA1 region of CA rats. *P < 0.05, CA rats (n=12) vs. control rats (n=10) and CA rats with rapamycin (n=15). (B): CA increased the levels of VEGF in the CA1 region of rats and VEGF was amplified by rapamycin. *P < 0.05 vs. control rats CA rats with rapamycin. N=10 in control; n=12 in CA rats and n=15 in CA rats with rapamycin. (C): CA increased the protein expression of VEGFR-2 and Caspase-3 in the hippocampus of rats; administration of rapamycin amplified upregulation of VEGFR-2 and attenuated Caspase-3. *P < 0.05 vs. control rats and CA rats with rapamycin. n=6 in each group.
neovascularisation as a downstream product of HIF-1α, which contributes to VEGF formation due to ischemic or hypoxic conditions [10] . Also, VEGF and its subtype receptor VEGFR-2 play an important role in pathologic angiogenesis [20, 21] . [23] . VEGFR-3 regulates lymphatic endothelial cell function and mediates lymphangiogenesis in response to VEGF [23, 24] . Considerable evidence shows that VEGFR-2 is specific intracellular signal cascades leading to proliferation, migration, survival and increased permeability, each of which contributes to the angiogenic response [23] . Accordingly, in the present study, we examined the involvement of VEGF subtype receptor VEGFR-2 in mTOR signal pathway in the process of neurological deficits after CA.
Caspases, a family of thiol proteases, regulate the apoptotic cascade and induction of CA activates neuronal caspases. In the death-signalling cascade, it is crucial that pro-caspase-3 is processed to its active form Caspase-3, and it has been reported that Caspase-3 is a principal target engaged in the reactive oxygen species-mediated apoptosis in human endothelial cells [25] . Thus, in the current study, we also determined the levels of cleaved Caspase-3 in the hippocampus tissues, as an indicator of cellular apoptosis, and we found that CA increases Caspase-3 in CA animals. This is consistent with the results observed in a previous study [9] . content of brain tissues compared to control animals. As rapamycin was given the increased mNSS and water content were attenuated in CA rats. *P < 0.05 vs. control rats and CA rats with rapamycin. N=10 in control; n=12 in CA rats and n=15 in CA rats with rapamycin. 
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